These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22336202)

  • 41. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary.
    Travis WD; Brambilla E; Noguchi M; Nicholson AG; Geisinger K; Yatabe Y; Powell CA; Beer D; Riely G; Garg K; Austin JH; Rusch VW; Hirsch FR; Jett J; Yang PC; Gould M;
    Proc Am Thorac Soc; 2011 Sep; 8(5):381-5. PubMed ID: 21926387
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic significance of the IASLC/ATS/ERS classification in Chinese patients-A single institution retrospective study of 292 lung adenocarcinoma.
    Gu J; Lu C; Guo J; Chen L; Chu Y; Ji Y; Ge D
    J Surg Oncol; 2013 Apr; 107(5):474-80. PubMed ID: 22952152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between high-resolution computed tomography findings and the IASLC/ATS/ERS classification of small lung adenocarcinomas in Japanese patients.
    Kudo Y; Matsubayashi J; Saji H; Akata S; Shimada Y; Kato Y; Kakihana M; Kajiwara N; Ohira T; Nagao T; Ikeda N
    Lung Cancer; 2015 Oct; 90(1):47-54. PubMed ID: 26259875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathologic classification of adenocarcinoma of lung.
    Van Schil PE; Sihoe AD; Travis WD
    J Surg Oncol; 2013 Oct; 108(5):320-6. PubMed ID: 24006216
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
    Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
    Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification.
    Russell PA; Wainer Z; Wright GM; Daniels M; Conron M; Williams RA
    J Thorac Oncol; 2011 Sep; 6(9):1496-504. PubMed ID: 21642859
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma.
    Guo Z; Yi F; Yin W; Zhang Y; Li Q; Gu Y; Xiao Y; Cao B; Ma L; Liang L
    Thorac Cancer; 2017 May; 8(3):159-169. PubMed ID: 28220630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. European respiratory society/american thoracic society/international association for the study of lung cancer international multidisciplinary classification of lung adenocarcinoma: state of the art.
    Witt C
    J Thorac Oncol; 2011 Aug; 6(8):1451. PubMed ID: 21847068
    [No Abstract]   [Full Text] [Related]  

  • 49. A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.
    Kadota K; Suzuki K; Kachala SS; Zabor EC; Sima CS; Moreira AL; Yoshizawa A; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
    Mod Pathol; 2012 Aug; 25(8):1117-27. PubMed ID: 22499226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expert opinion: role of percutaneous biopsy of part-solid nodules in the IASLC/ATS/ERS international multidisciplinary classification of lung adenocarcinoma.
    Franks TJ; Galvin JR; Jett JR; Naidich DP; Boiselle PM
    J Thorac Imaging; 2011 Aug; 26(3):189. PubMed ID: 21778873
    [No Abstract]   [Full Text] [Related]  

  • 51. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].
    Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rare subtypes of adenocarcinoma of the lung.
    Ou SH; Kawaguchi T; Soo RA; Kitaichi M
    Expert Rev Anticancer Ther; 2011 Oct; 11(10):1535-42. PubMed ID: 21999127
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas.
    Warth A; Stenzinger A; von Brünneck AC; Goeppert B; Cortis J; Petersen I; Hoffmann H; Schnabel PA; Weichert W
    Eur Respir J; 2012 Nov; 40(5):1221-7. PubMed ID: 22408209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Two-gene signature improves the discriminatory power of IASLC/ATS/ERS classification to predict the survival of patients with early-stage lung adenocarcinoma.
    Sun Y; Hou L; Yang Y; Xie H; Yang Y; Li Z; Zhao H; Gao W; Su B
    Onco Targets Ther; 2016; 9():4583-91. PubMed ID: 27524912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histopathologic characteristics of lung adenocarcinomas with epidermal growth factor receptor mutations in the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification.
    Shim HS; Lee DH; Park EJ; Kim SH
    Arch Pathol Lab Med; 2011 Oct; 135(10):1329-34. PubMed ID: 21970488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subtyping lung adenocarcinoma according to the novel 2011 IASLC/ATS/ERS classification: correlation with patient prognosis.
    Okada M
    Thorac Surg Clin; 2013 May; 23(2):179-86. PubMed ID: 23566969
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS).
    Tang ER; Schreiner AM; Pua BB
    J Thorac Dis; 2014 Oct; 6(Suppl 5):S489-501. PubMed ID: 25349701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The new histologic classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: the experience of a French cohort.
    Mansuet-Lupo A; Bobbio A; Blons H; Becht E; Ouakrim H; Didelot A; Charpentier MC; Bain S; Marmey B; Bonjour P; Biton J; Cremer I; Dieu-Nosjean MC; Sautès-Fridman C; Régnard JF; Laurent-Puig P; Alifano M; Damotte D
    Chest; 2014 Sep; 146(3):633-643. PubMed ID: 24676429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classification.
    Warth A; Cortis J; Fink L; Fisseler-Eckhoff A; Geddert H; Hager T; Junker K; Kayser G; Kitz J; Länger F; Morresi-Hauf A; Ott G; Petersen I; Stenzinger A; Soltermann A; Ting S; Tischler V; Vollmer E; Schnabel PA; Weichert W;
    Virchows Arch; 2012 Aug; 461(2):185-93. PubMed ID: 22729141
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathological diagnosis and classification of lung cancer in small biopsies and cytology: strategic management of tissue for molecular testing.
    Travis WD; Rekhtman N
    Semin Respir Crit Care Med; 2011 Feb; 32(1):22-31. PubMed ID: 21500121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.